(Q37655092)

21 August 2017

Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion (English)

1 reference

21 August 2017

hepatocellular carcinoma

1 reference

Asmaa Gomaa

13

0 references

Mercedes Iñarrairaegui

Mercedes Iñarrairaegui

12

0 references

Imam Waked

Imam Waked

1

0 references

Stephen L Chan

Stephen L Chan

4

0 references

Bruno Sangro

Bruno Sangro

16

0 references

Winnie Yeo

Winnie Yeo

8

0 references

Takashi Kumada

18

Takashi Kumada

1 reference

21 August 2017

7

Toshifumi Tada

1 reference

21 August 2017

3

Hidenori Toyoda

1 reference

21 August 2017

2

Sarah Berhane

1 reference

21 August 2017

17

Paul Lai

1 reference

21 August 2017

14

Arndt Vogel

1 reference

21 August 2017

10

Dominik Bettinger

1 reference

21 August 2017

Nicholas Stern

5

1 reference

21 August 2017

Daniel Palmer

6

1 reference

21 August 2017

Frankie Mo

9

1 reference

21 August 2017

Martha M Kirstein

11

1 reference

21 August 2017

Tim Meyer

15

1 reference

21 August 2017

Philip J Johnson

19

1 reference

21 August 2017

language of work or name

English

0 references

publication date

26 January 2017

1 reference

British Journal of Cancer

21 August 2017

1 reference

21 August 2017

116

1 reference

21 August 2017

4

1 reference

21 August 2017

448-454

1 reference

Creative Commons Attribution 4.0 International

21 August 2017

start time

26 January 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/bjc.2016.423

0 references

cites work

Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Management of hepatocellular carcinoma with portal vein thrombosis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Chemoembolization for intermediate HCC: is there proof of survival benefit?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Management of hepatocellular carcinoma: An update

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Sorafenib in advanced hepatocellular carcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Prognosis of hepatocellular carcinoma: the BCLC staging classification

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Evaluating the yield of medical tests

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular Carcinoma.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

New simple prognostic score for primary biliary cirrhosis: Albumin-bilirubin score.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5318968

Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers

1 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2016.423

A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2016.423

inferred from DOI database lookup

7 January 2021

based on heuristic

Treatment strategy for hepatocellular carcinoma with major portal vein or inferior vena cava invasion: a single institution experience

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2016.423

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/BJC.2016.423

1 reference

Dimensions Publication ID

21 August 2017

1074228027

0 references

Fatcat ID

release_7z6mhgtjdzdxzgyecc2hhlkhe4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7z6mhgtjdzdxzgyecc2hhlkhe4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

21 August 2017

1 reference